Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Parathyroid Neoplasms

1-methyl-3-isobutylxanthine has been researched along with Parathyroid Neoplasms in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Parathyroid Neoplasms: Tumors or cancer of the PARATHYROID GLANDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martina, V1
Bruno, GA1
Brancaleoni, V1
Zumpano, E1
Tagliabue, M1
Fornengo, R1
Gasparri, G1
Pescarmona, GP1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Parathyroid Neoplasms

ArticleYear
Calcium blood level modulates endogenous nitric oxide action: effects of parathroidectomy in patients with hyperparathyroidism.
    The Journal of endocrinology, 1998, Volume: 156, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Adenoma; Blood Platelets; Calcium; Cyclic GMP; Female; Humans; Hyperpar

1998